- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * CHELEMEDOS ROGER L	2. Issuer Name and Ticker or Trading Symbol LONGS DRUG STORES CORP [ LDG ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                      _____ 10% Owner __ X __ Officer (give title below)      _____ Other (specify below) SVP-FINANCE, CONTROLLER,TREAS.
(Last)          (First)          (Middle) C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 10/20/2008
(Street) WALNUT CREEK, CA 94596 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/20/2008		A		13200   (1)	A	$0	13200	D
Common Stock	10/20/2008		A		4000   (2)	A	$0	4000	D
Common Stock	10/20/2008		A		2168   (2)	A	$0	2168	D
Common Stock	10/20/2008		D		13200   (3)	D	$71.50	0	D
Common Stock	10/20/2008		D		4000   (3)	D	$71.50	0	D
Common Stock	10/20/2008		D		2168   (3)	D	$71.50	0	D
Common Stock	10/20/2008		D		13500   (4)	D	$71.50	0	D
Common Stock	10/20/2008		D		6000   (4)	D	$71.50	0	D
Common Stock	10/20/2008		D		5719   (4)	D	$71.50	0	D
Common Stock	10/20/2008		D		1150   (4)	D	$71.50	0	D
Common Stock	10/20/2008		U		715   (5) (6)	D	$71.50	0	D
Common Stock	10/20/2008		U		8794   (6)	D	$71.50	0	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$15.37	10/20/2008		D  (7)			9000	3/28/2004	3/28/2013	Common Stock	9000	$71.50	0	D
Stock Option (Right to Buy)	$24.40	10/20/2008		D  (7)			6000	11/24/2004	11/24/2013	Common Stock	6000	$71.50	0	D
Stock Option (Right to Buy)	$23.56	10/20/2008		D  (7)			5000	10/12/2005	10/12/2014	Common Stock	5000	$71.50	0	D
Stock Option (Right to Buy)	$30.52	10/20/2008		D  (7)			5000	3/7/2006	3/9/2015	Common Stock	5000	$71.50	0	D

Explanation of Responses:
( 1)	In accordance with the terms of the Agreement and Plan of Merger, dated as of August 12, 2008, among Longs Drug Stores Corporation, CVS Caremark Corporation and Blue Mergersub Corp. (the "Merger Agreement"), each outstanding right to earn a restricted share under Longs' 2008/2009 performance-based restricted stock grant program ('Performance Share") was deemed to be earned at maximum.
( 2)	In accordance with the terms of the Merger Agreement, each outstanding right to earn a restricted share under Longs' 2009/2010 performance-based restricted stock grant program ('Performance Share") was deemed to be earned at target, with that portion of such performance award not dependent solely on Longs' performance in 2009 being prorated by a fraction, the numerator of which was the number of days elapsed between February 1, 2008 and October 20, 2008 and the denominator of which is the number of days in the full 2009/2010 performance cycle.
( 3)	In accordance with the terms of the Merger Agreement, on October 20, 2008, each Performance Share was converted into the right to receive $71.50 per share in cash.
( 4)	In accordance with the terms of the Merger Agreement, each outstanding unvested restricted share vested on October 20, 2008 and was converted into the right to receive $71.50 per share in cash.
( 5)	These shares were held pursuant to Longs Drug Stores California, Inc. 401(k) Plan. The number of shares is based on a report prepared by the Plan as of 10/16/08.
( 6)	Pursuant to the tender offer commenced under the Merger Agreement, the shares listed were exchanged for the right to receive $71.50 per share in cash.
( 7)	Pursuant to the Merger Agreement, this option, which provided for vesting in four (4) equal annual installments beginning one year from the grant date, was converted into the right to receive a cash payment equal to the number of shares of Longs common stock underlying the option multiplied by the difference between the per share exercise price and the per share merger consideration of $71.50.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
CHELEMEDOS ROGER L C/O LONGS DRUG STORES CORPORATION 141 NORTH CIVIC DRIVE WALNUT CREEK, CA 94596			SVP-FINANCE, CONTROLLER,TREAS.

Signatures
/s/ Roger L. Chelemedos		10/22/2008
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.